RecruitingNCT03160274

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions


Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment

2,000 participants

Start Date

Oct 19, 2005

Study Type

OBSERVATIONAL

Conditions

Summary

Pheochromocytomas and paragangliomas are neural crest-derived tumors of the nervous system that are often inherited and genetically heterogeneous. Genetic screening is recommended for patients and their relatives, and can guide clinical decisions. However, a mutation is not found in all cases. The aims of this proposal are to: 1) to map gene(s) involved in pheochromocytoma, and 2) identify genotype-phenotype correlations in patients with pheochromocytoma/paraganglioma of various genetic origins.


Eligibility

Inclusion Criteria4

  • diagnosis of pheochromocytoma and or paraganglioma
  • family member with diagnosis of pheochromocytoma and or paraganglioma
  • diagnosis of a pheochromocytoma- and or paraganglioma-associated condition
  • family member with diagnosis of a pheochromocytoma- and or paraganglioma-associated condition

Exclusion Criteria1

  • unconfirmed diagnosis of pheochromocytoma and/or paraganglioma or associated condition

Interventions

GENETICGenetic screening

Germline and/or tumor samples will be screened for mutations


Locations(1)

University of Texas Health Science Center

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03160274


Related Trials